Clinical trials
Phase 2/3 Recurrence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 1 |
| Amgen | 1 |
| BioNTech SE | 1 |
| Children's Oncology Group | 1 |
| Geron Corporation | 1 |
| Global Coalition for Adaptive Research | 1 |
| Kiniksa Pharmaceuticals International, plc | 1 |
| London Health Sciences Centre | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Tocagen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 11 |
| Demyelinating Diseases | 2 |
| Glioblastoma | 2 |
| Optic Neuritis | 2 |
| Astrocytoma | 1 |
| Clostridium Infections | 1 |
| Head and Neck Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Ischemic Attack, Transient | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.